| Followers | 14 |
| Posts | 1733 |
| Boards Moderated | 0 |
| Alias Born | 06/14/2018 |
Monday, June 12, 2023 10:49:27 AM
Yes, you are absolutely correct once again. "Still the same people with no new faces except for the CMO."
With the CEO Peter Hoang gone and a new CFO, can an intelligent person actually say "Still the SAME people"?
Does that mean when somebody like PH disappears and Anthony Kim comes in as the new CFO, it is "STILL the SAME people"?
"The only difference is a stronger link to AlloVir through CEO Vera and a Director who now owns the manufacturing end of the process."
Would an intelligent person REALLY say that with new cash from the CellReady deal and a new trial started and dosed and a management shakeup that the ONLY DIFFERENCE is "a stronger link to AlloVir", which is meaningless?
Would an intelligent person REALLY say that "the ONLY DIFFERENCE is a stronger link to AlloVir" is the reason that the stock price has gone from $1.25 to $3.25 in the last month, getting close to tripling?
Yes, you keep on beating the same old tired dead horses if it makes you feel better about yourself.
I think an intelligent person WOULD say that foolish statements come from foolish people.
With the CEO Peter Hoang gone and a new CFO, can an intelligent person actually say "Still the SAME people"?
Does that mean when somebody like PH disappears and Anthony Kim comes in as the new CFO, it is "STILL the SAME people"?
"The only difference is a stronger link to AlloVir through CEO Vera and a Director who now owns the manufacturing end of the process."
Would an intelligent person REALLY say that with new cash from the CellReady deal and a new trial started and dosed and a management shakeup that the ONLY DIFFERENCE is "a stronger link to AlloVir", which is meaningless?
Would an intelligent person REALLY say that "the ONLY DIFFERENCE is a stronger link to AlloVir" is the reason that the stock price has gone from $1.25 to $3.25 in the last month, getting close to tripling?
Yes, you keep on beating the same old tired dead horses if it makes you feel better about yourself.
I think an intelligent person WOULD say that foolish statements come from foolish people.
Recent MRKR News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/20/2026 08:08:49 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/20/2026 08:07:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/20/2026 08:05:49 PM
- Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results • GlobeNewswire Inc. • 03/18/2026 09:31:30 PM
- Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/18/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 09:06:45 PM
- Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology • GlobeNewswire Inc. • 01/26/2026 12:00:00 PM
- Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer • GlobeNewswire Inc. • 01/05/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:10:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:01:15 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/17/2025 09:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 12:20:47 PM
- Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/14/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:29:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 12:36:59 PM
- Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors • GlobeNewswire Inc. • 11/05/2025 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 10:09:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 10:03:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 09:54:39 PM
- Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting • GlobeNewswire Inc. • 11/03/2025 02:15:00 PM
- Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program • GlobeNewswire Inc. • 10/06/2025 11:30:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 11:30:37 AM
- Marker Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 08/28/2025 12:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2025 11:16:20 AM
